Mosby's 2018 Nursing Drug Reference (Record no. 4123)

MARC details
000 -LEADER
fixed length control field 02785nam a22002297a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305192300.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220113b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780323531894
International Standard Book Number 032353189X
040 ## - CATALOGING SOURCE
Transcribing agency Data Centre
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Linda Skidmore-Roth
9 (RLIN) 28698
245 ## - TITLE STATEMENT
Title Mosby's 2018 Nursing Drug Reference
250 ## - EDITION STATEMENT
Edition statement 31th Edition
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. 3251 Riverport Lane St. Louis, Missouri 63043
Name of publisher, distributor, etc. Elsevier Health Sciences
Date of publication, distribution, etc. 2017
300 ## - PHYSICAL DESCRIPTION
Extent 1408 pages
490 ## - SERIES STATEMENT
Series statement SKIDMORE NURSING DRUG REFERENCE
520 ## - SUMMARY, ETC.
Summary, etc. Choose the drug handbook trusted for nearly 30 years! From the leading name in nursing, Mosby’s 2018 Nursing Drug Reference is a full-color portable nursing drug handbook that makes it easy to find the most vital information on the drugs that nurses administer most frequently. More than 5,000 drugs are profiled — including 20-30 new entries for drugs recently approved by the FDA. . No other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. Backed with practical online resources, Mosby’s Nursing Drug Reference proves there is a difference in drug guides. It’s Mosby’s bestselling drug reference for nurses!<br/><br/>Black Box Warnings provide alerts to FDA warnings of dangerous or life-threatening drug reactions.<br/>Safety Alert icon highlights the most critical drug interactions and side effects.<br/>Common and life-threatening side effects are organized by body system, showing signs to watch for during assessments.<br/>Coverage of IV drug administration highlights dosage and IV administration instructions, including safety considerations and Y-site, syringe, and additive compatibilities.<br/>Alphabetical organization by generic name provides quick and easy access to specific drugs, and a full-color design highlights important information.<br/>Nursing Process steps are used as the framework for organizing all nursing care information.Overview of drug categories explains the safe administration of common classes of drugs, as well as their common side effects and interactions.<br/>Cross-references indicate drug information that may be found in the appendices.<br/>Complete pharmacokinetic information includes the mechanism and absorption of the drug as well as its action, duration, and excretion.<br/>NEW! 20-30 added monographs provide up-to-date content on newly released drugs.<br/>NEW! BEERS indications included for selected monographs.<br/>NEW! Drugs with genetic indications identifiable by easy to spot icon.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / Nursing / Pharmacology
9 (RLIN) 28586
General subdivision Medical › Nursing › Pharmacology
9 (RLIN) 28587
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   01/13/2022   EBS8594 01/13/2022 01/13/2022 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024